RXC008

Asset

Gastrointestinal-restricted pan-ROCK inhibitor

Stage: Phase 1
Modality: Small molecule
Target: ROCK1; 1
Indication: 0
Trials: 1
Developer

Indications

1

Fibrostenotic Crohn's disease
Phase 1, redxpharma.com, 7 Oct 2026

In the full profile

Targets and what it contains2
Owner and partners1
Evidence for its targets1
Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026, 1 source